Myalloy

Alloy is a telehealth platform that connects women with licensed physicians who specialize in menopause care, providing personalized treatment plans — including hormone therapy — without requiring multiple in-person doctor visits. Their YouTube channel pairs that clinical access with expert Q&As and educational videos so women can understand their options before they ever speak to a provider.

Yes, Alloy's featured physicians have addressed an active shortage of estrogen patches in the U.S., explaining its causes and walking women through alternative forms of estrogen therapy that may be easier to obtain. Their content specifically advises women to seek out a menopause-knowledgeable provider rather than simply going without treatment while the shortage continues.

Alloy cited Melinda Gates' experience — reportedly needing three separate doctors before receiving proper menopause care — as a striking example of how broken the system is for women at every income level. The point is that if someone with extraordinary resources struggled to get diagnosed and treated, it illustrates just how widespread the gap in menopause medicine really is.

Alloy has highlighted research showing that only around 6% of women who seek menopause care end up receiving it, attributing the gap to undertrained physicians, persistent stigma, and outdated fears around hormone therapy that were fueled by a flawed study from the early 2000s. Their platform exists specifically to route women past that barrier and toward doctors who treat menopause as a legitimate medical condition.

Alloy covers GLP-1 medications as part of their broader content on metabolic changes during menopause, since unexplained weight gain is one of the most common and frustrating symptoms women report. Whether a GLP-1 is appropriate for any individual depends on a clinical consultation with an Alloy provider, as eligibility and treatment plans are personalized.

HRT (hormone replacement therapy) and MHT (menopausal hormone therapy) describe essentially the same category of treatment — MHT is the newer preferred medical term that frames the goal as managing a hormonal transition rather than simply replacing something lost. Alloy uses both terms in their content and works with physicians who tailor the type, delivery method, and dose of these treatments to each patient.

Alloy explicitly serves women in perimenopause — the transitional phase that can begin years before a final period — and produces dedicated content under hashtags like #perimenopausesymptoms to reach women who may not yet recognize that their mood swings, sleep issues, or brain fog have a hormonal explanation. Their care model covers every stage of the hormonal shift, not just the post-menopausal phase.

Alloy's scope goes well beyond hot flashes and covers weight changes, skin quality, hair thinning, low libido, and overall sexual wellness — areas that are frequently dismissed in conventional medical settings. Their doctors build personalized treatment plans that address the full picture of how menopause affects the body.

Yes, Alloy features licensed medical doctors in their educational content — physicians who also provide clinical care through the platform, not just on-camera talent. The videos are designed so women arrive at their appointments already informed about treatment options like hormone therapy, estrogen patches, and newer emerging therapies.

Alloy covers peptides as part of a broader conversation about emerging therapies relevant to menopause-related concerns such as skin health, body composition, and energy levels. Their content aims to keep women informed about the evolving landscape of options alongside more established treatments, though individual suitability always depends on a provider consultation.